Clinical trials
Phase 2 Bone Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Active, not recruiting | 4 |
| Enrolling by invitation | 2 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BioMarin Pharmaceutical | 5 |
| Alexion Pharmaceuticals, Inc. | 4 |
| Northwestern University | 4 |
| QED Therapeutics, a BridgeBio company | 4 |
| AstraZeneca | 1 |
| Celgene | 1 |
| National Institute of Dental and Craniofacial Research (NIDCR) | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Pfizer | 1 |
| Tarsa Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bone Diseases | 24 |
| Musculoskeletal Diseases | 13 |
| Dwarfism | 9 |
| Achondroplasia | 8 |
| Osteochondrodysplasias | 6 |
| Bone Diseases, Metabolic | 5 |
| Genetic Diseases, Inborn | 5 |
| Mucopolysaccharidosis IV | 5 |
| Osteoporosis | 5 |
| Bone Diseases, Developmental | 4 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.